经典和多不和脂肪酸类饮食在控制儿科耐火性的有效性和耐受性 - 一项随机研究
Subhasree Ray1, Janak Nathan2, Meena Godhia3
1Corporate Medical Services, Reliance Industries Limited, Mumbai, India.
Epilepsy research
|June 22, 2024
概括
经典的类饮食 (CKD) 和多不和脂肪酸类饮食 (PUFAKD) 在儿童中显示出类似的发作减少. 与PUFAKD相比,CKD因耐受性和遵守性更好而优越,用于耐火性的管理.
科学领域:
- 神经学 神经学
- 儿科神经学 儿科神经学
- 营养神经科学 营养神经科学
背景情况:
- 儿童中耐火性症带来了重大管理挑战.
- 性饮食是药物耐药性的已知疗法.
- 新型配方,如多不和脂肪酸类饮食 (PUFAKD),需要有效性和耐受性评估.
研究的目的:
- 为了比较经典性饮食 (CKD) 与儿科耐火性中的PUFAKD的疗效和耐受性.
- 评估12个月的发作频率减少和不良事件.
- 为了评估饮食遵守和控制之间的相关性.
主要方法:
- 一项随机试验涉及52名患有耐火性的儿童 (年龄在2-10岁).
- 两个组:CKD (n=25) 和PUFAKD (n=27),脂肪:碳水化合物+蛋白质比为2.2:1-4:1.
- PUFAKD使用的不和脂肪具有特定的omega-3:omega-6比率;基水平通过测量棒进行监测.
主要成果:
- 这两种饮食都显著降低了发作频率 (p=0.001),两组之间没有显著差异 (p=0.537).
- 平均发作减少率为71.1%,较高的遵守率与较大的发作减少率相关 (p=0.042).
- 与CKD组相比,PUFAKD组的恶心 (p=0.033) 和吐 (p=0.014) 更多.
结论:
- CKD和PUFAKD在减少儿科耐性发作中的有效性相似.
- 与PUFAKD相比,CKD显示出更好的耐受性和合规性.
- 对于这一群体来说,CKD仍然是首选的饮食疗法,因此需要对PUFAKD变异进行进一步的试验.
相关概念视频
01:14Antiepileptic Drugs: Glutamate Antagonists
319
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
319
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
286
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
286
01:08Antiepileptic Drugs: Sodium Channel Blockers
508
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
508
01:17Antiepileptic Drugs: Calcium Channel Blockers
369
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
369
01:24Arteries of the Lower Limbs
187
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
187
01:20Antiepileptic Drugs: Potassium Channel Activators
169
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
169